Conserved HA-peptides expressed along with flagellin in Trichoplusia ni larvae protects chicken against intranasal H7N1 HPAIV challenge
Ver/Abrir
Autor/a
Sisteré-Oró, Marta
Martínez-Pulgarín, Susana
Solanes, David
Veljkovic, Veljko
Córdoba, Lorena
Cordón, Ivan
Escribano, José M.
Fecha de publicación
2019-11-14ISSN
0264-410X
Resumen
The immunization of poultry where H5 and H7 influenza viruses (IVs) are endemic is one of the strategies to prevent unexpected zoonoses. Our group has been focused on conserved HA-epitopes as potential vaccine candidates to obtain multivalent immune responses against distinct IV subtypes. In this study, two conserved epitopes (NG-34 and CS-17) fused to flagellin were produced in a Baculovirus platform based on Trichoplusia ni larvae as living biofactories. Soluble extracts obtained from larvae expressing "flagellin-NG34/CS17 antigen" were used to immunize chickens and the efficacy of the vaccine was evaluated against a heterologous H7N1 HPAIV challenge in chickens. The flagellin-NG34/CS17 vaccine protected the vaccinated chickens and blocked viral shedding orally and cloacally. Furthermore, no apparent clinical signs were monitored in 10/12 vaccinated individuals. The mechanism of protection conferred is under investigation.
Tipo de documento
Artículo
Versión del documento
Versión publicada
Lengua
English
Materias (CDU)
619 - Veterinaria
Páginas
7
Publicado por
Elsevier
Publicado en
Vaccine
Citación
Sisteré-Oró, Marta, Susana Martínez-Pulgarín, David Solanes, Veljko Veljkovic, Sergi López-Serrano, Lorena Córdoba, Ivan Cordón, José M. Escribano, and Ayub Darji. 2020. "Conserved HA-Peptides Expressed Along With Flagellin In Trichoplusia Ni Larvae Protects Chicken Against Intranasal H7N1 HPAIV Challenge". Vaccine 38 (3): 416-422. Elsevier BV. doi:10.1016/j.vaccine.2019.11.006.
Número del acuerdo de la subvención
MINECO/Programa estatal de I+D+I orientada a los retos de la sociedad/AGL2013-48923-C2-2-R/ES/Nuevas estrategias vacunales frente a enfermedades víricas ganaderas empleando pseudopartículas virales modificadas/
EC/H2020/730964/EU/European Vaccine Research and Development Infrastructure/TRANSVAC2
Program
Sanitat Animal
Este ítem aparece en la(s) siguiente(s) colección(ones)
- ARTICLES CIENTÍFICS [2811]
Excepto si se señala otra cosa, la licencia del ítem se describe como http://creativecommons.org/licenses/by-nc-nd/4.0/